Search research articles
Contact Us
Filters
Showing results (131-140 of 175) with videos related to
Page
of 18
Sort By:
Transplantation and Cellular Therapy
|
September 2, 2021
Safety and Efficacy of Pembrolizumab Prior to Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia
Nicholas P Tschernia, Vaibhav Kumar, Dominic T Moore, et al.
JAMA Oncology
|
June 7, 2018
Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors
Ryan N Ptashkin, Diana L Mandelker, Catherine C Coombs, et al.
Blood Cancer Journal
|
May 7, 2026
Docirbrutinib is a pan-mutant BTK inhibitor and inhibits B-cell receptor signaling in chronic lymphocytic leukemia cells in preclinical and early clinical investigations
Natalia Timofeeva, Breana Herrera, Hitomi Fujiwara, et al.
Journal of Oncology Practice
|
February 1, 2019
Evaluating the Impact of Treatment Care Planning on Quality Measures
Gabrielle B Rocque, Courtney P Williams, Amanda R Hathaway, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 8, 2018
Managing Clonal Hematopoiesis in Patients With Solid Tumors
Kelly L Bolton, Nancy K Gillis, Catherine C Coombs, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 7, 2025
Feasibility of Bruton's Tyrosine Kinase Inhibitor Discontinuation in Chronic Lymphocytic Leukemia: The Patient Perspective
Deborah M Stephens, Chris Stewart, Liza Avruch, et al.
American Journal of Hematology
|
January 27, 2021
Genomic characteristics and prognostic significance of co-mutated ASXL1/SRSF2 acute myeloid leukemia
Daniel R Richardson, David M Swoboda, Dominic T Moore, et al.
Cell Stem Cell
|
August 15, 2017
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes
Catherine C Coombs, Ahmet Zehir, Sean M Devlin, et al.
Cancer
|
April 9, 2026
Clinical strategies for lymphoma management: Recommendations from the Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Consensus Conference 2025
Alexey V Danilov, Catherine C Coombs, Tycel Phillips, et al.
Ebiomedicine
|
May 6, 2018
Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents
Matthieu Duchmann, Fevzi F Yalniz, Alessandro Sanna, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 175) with videos related to
Sort By:
Page
of 18
Transplantation and Cellular Therapy
|
September 2, 2021
Safety and Efficacy of Pembrolizumab Prior to Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia
Nicholas P Tschernia, Vaibhav Kumar, Dominic T Moore, et al.
JAMA Oncology
|
June 7, 2018
Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors
Ryan N Ptashkin, Diana L Mandelker, Catherine C Coombs, et al.
Blood Cancer Journal
|
May 7, 2026
Docirbrutinib is a pan-mutant BTK inhibitor and inhibits B-cell receptor signaling in chronic lymphocytic leukemia cells in preclinical and early clinical investigations
Natalia Timofeeva, Breana Herrera, Hitomi Fujiwara, et al.
Journal of Oncology Practice
|
February 1, 2019
Evaluating the Impact of Treatment Care Planning on Quality Measures
Gabrielle B Rocque, Courtney P Williams, Amanda R Hathaway, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 8, 2018
Managing Clonal Hematopoiesis in Patients With Solid Tumors
Kelly L Bolton, Nancy K Gillis, Catherine C Coombs, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 7, 2025
Feasibility of Bruton's Tyrosine Kinase Inhibitor Discontinuation in Chronic Lymphocytic Leukemia: The Patient Perspective
Deborah M Stephens, Chris Stewart, Liza Avruch, et al.
American Journal of Hematology
|
January 27, 2021
Genomic characteristics and prognostic significance of co-mutated ASXL1/SRSF2 acute myeloid leukemia
Daniel R Richardson, David M Swoboda, Dominic T Moore, et al.
Cell Stem Cell
|
August 15, 2017
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes
Catherine C Coombs, Ahmet Zehir, Sean M Devlin, et al.
Cancer
|
April 9, 2026
Clinical strategies for lymphoma management: Recommendations from the Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Consensus Conference 2025
Alexey V Danilov, Catherine C Coombs, Tycel Phillips, et al.
Ebiomedicine
|
May 6, 2018
Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents
Matthieu Duchmann, Fevzi F Yalniz, Alessandro Sanna, et al.
Page
of 18